Continuous Bioprocessing Market by Product (Filtration, Chromatography, Bioreactor, Centrifuge), Application [Commercial (Monoclonal Antibodies, Vaccine Production), Research], and End User (Pharma and Biotech, CDMOs)– Global Forecasts to 2027

  • Report ID:MRHC - 104380
  • Pages: 250
  • Feb 2020
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours

1. Introduction
    1.1. Market Definition
    1.2. Market Ecosystem
    1.3. Currency
    1.4. Key Stakeholders

2. Research Methodology
    2.1. Research Approach
    2.2. Data Collection & Validation
           2.2.1. Secondary Research
           2.2.2. Primary Research
    2.3. Market Assessment
          2.3.1. Market Size Estimation
                    2.3.1.1. Bottom-Up Approach
                    2.3.1.2. Top-Down Approach
                    2.3.1.3. Growth Forecast
          2.3.2. Market Share Analysis
    2.4. Assumptions for the Study
    2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
    4.1. Introduction
    4.2. Market Dynamics
          4.2.1. Drivers
                    4.2.1.1. Growing Demand for Biopharmaceuticals
                    4.2.1.2. Development of New Technologies and Products Related to Continuous Bioprocessing
                    4.2.1.3. Increase in Government Support for Biopharmaceutical Research
          4.2.2. Restraints
                    4.2.2.1. Limitations Associated with Continuous Bioprocessing
                    4.2.2.2. Complex and Technically Unfeasible Nature of Continuous Bioprocessing in Downstream Processes
                    4.2.2.3. Dearth of Bioprocessing Professionals
          4.2.3. Opportunities
                    4.2.3.1. Significant Opportunities from Emerging Asia-Pacific and Latin American Markets
                    4.2.3.2. Growing Approval of Personalized Medicines
          4.2.4. Challenge
                   4.2.4.1. Strict Regulatory Considerations Demanding High Quality and Contaminant Free Biopharmaceutical Product
          4.2.5. Trend
                    4.2.5.1. Growing Penetration of Single-Use Technology in Continuous Bioprocessing

5. Continuous Bioprocessing Market, by Product
    5.1. Introduction
    5.2. Filtration Systems and Consumables
    5.3. Chromatography Systems and Consumables
    5.4. Bioreactors
    5.5. Sterilizers
    5.6. Centrifuges
    5.7. Incubators & Shakers
    5.8. Mixing Systems
    5.9. Cell Culture Media and Reagents
    5.10. Other Instruments & Consumables
    5.11. Services

6. Continuous Bioprocessing Market, by Application
    6.1. Introduction
    6.2. Commercial Application
           6.2.1. Monoclonal Antibody Production
           6.2.2. Therapeutic Protein Production
           6.2.3. Vaccine Production
           6.2.4. Cell and Gene Therapy
    6.3. Research Applications

7. Continuous Bioprocessing Market, by End User
    7.1. Introduction
    7.2. Pharmaceutical & Biotechnology Companies
    7.3. Contract Development and Manufacturing Organizations (CDMOs)
    7.4. Academic and Research Institutes

8. Continuous Bioprocessing Market, by Geography
    8.1. Introduction
    8.2. North America
           8.2.1. U.S.
           8.2.2. Canada
    8.3. Europe
           8.3.1. Germany
           8.3.2. U.K.
           8.3.3. France
           8.3.4. Italy
           8.3.5. Spain
           8.3.6. Rest of Europe
    8.4. Asia-Pacific
           8.4.1. Japan
           8.4.2. China
           8.4.3. India
           8.4.4. Rest of Asia-Pacific
    8.5. Latin America
    8.6. Middle East & Africa

9. Competitive Landscape
    9.1. Introduction
    9.2. Key Growth Strategies
    9.3. Competitive Benchmarking
    9.4. Market Share Analysis

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
      10.1. GE Healthcare (A Subsidiary of General Electronics)
      10.2. Merck KGaA
      10.3. Thermo Fisher Scientific Inc.
      10.4. Danaher Corporation
      10.5. Sartorius AG
      10.6. Bio-Rad Laboratories, Inc.
      10.7. Repligen Corporation
      10.8. Eppendorf AG
      10.9. Applikon Biotechnology B.V. (A Subsidiary of Getinge AB)
      10.10. 3M Company

11. Appendix
      11.1. Questionnaire
      11.2. Available Customization

List of Tables 

Table 1 Global Continuous Bioprocessing Market Drivers: Impact Analysis (2019-2025)
Table 2 Developments in Continuous Bioprocessing
Table 3 Global Continuous Bioprocessing Market Restraints: Impact Analysis (2019-2025)
Table 4 Drawbacks of Continuous Processing
Table 5 Global Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 6 Key Players Offering Filtration Systems and Consumables
Table 7 Global Filtration Systems and Consumables Market Size, by Region/Country, 2017-2027 ($Million)
Table 8 Key Players Offering Chromatography Systems and Consumables
Table 9 Global Chromatography Systems and Consumables Market Size, by Region/Country, 2017-2027 ($Million)
Table 10 Key Players Offering Bioreactors
Table 11 Global Bioreactors Market Size, by Region/Country, 2017-2027 ($Million)
Table 12 Key Players Offering Sterilizers
Table 13 Global Sterilizers Market Size, by Region/Country, 2017-2027 ($Million)
Table 14 Key Players Providing Centrifuges
Table 15 Global Centrifuges Market Size, by Region/Country, 2017-2027 ($Million)
Table 16 Key Players Offering Incubators and Shakers
Table 17 Global Incubators and Shakers Market Size, by Region/Country, 2017-2027 ($Million)
Table 18 Key Players Offering Mixing Systems
Table 19 Global Mixing Systems Market Size, by Region/Country, 2017-2027 ($Million)
Table 20 Key Players Offering Cell Culture Media and Reagents
Table 21 Global Cell Culture Media and Reagents Market Size, by Region/Country, 2017-2027 ($Million)
Table 22 Global Continuous Bioprocessing Market Size for Other Instruments and Consumables, by Region/Country, 2017-2027 ($Million)
Table 23 Key Players Offering Services
Table 24 Global Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 25 Global Continuous Bioprocessing Market Size for Commercial Applications, by Type by Type, 2017-2027 ($Million)
Table 26 Global Continuous Bioprocessing Market Size for Commercial Applications, by Type by Region/Country, 2017-2027 ($Million)
Table 27 Global Continuous Bioprocessing Market Size for Monoclonal Antibody Production, by Region/Country, 2017-2027 ($Million)
Table 28 Global Continuous Bioprocessing Market Size for Therapeutic Protein Production, by Region/Country, 2017-2027 ($Million)
Table 29 Global Continuous Bioprocessing Market Size for Vaccine Production, by Region/Country, 2017-2027 ($Million)
Table 30 Global Continuous Bioprocessing Market Size for Cell and Gene Therapy, by Region/Country, 2017-2027 ($Million)
Table 31 Global Continuous Bioprocessing Market Size for Research Applications, by Region/Country, 2017-2027 ($Million)
Table 32 Continuous Bioprocessing Market, by End User, 2017-2027 ($Million)
Table 33 Global Continuous Bioprocessing Market Size for Pharmaceutical and Biotechnology Companies, by Country/Region, 2017-2027 ($Million)
Table 34 Global Continuous Bioprocessing Market Size for Contract Research and Development Organizations (CDMOs), by Country/Region, 2017-2027 ($Million)
Table 35 Global Continuous Bioprocessing Market Size for Academic and Research Institutes, by Country/Region, 2017-2027 ($Million)
Table 36 Global Continuous Bioprocessing Market Size, by Country/Region, 2017-2027 ($Million)
Table 37 North America: Continuous Bioprocessing Market Size, by Country, 2017-2027 ($Million)
Table 38 North America: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 39 North America: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 40 North America: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 41 North America: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 42 U.S.: Key Macro indicators
Table 43 U.S.: Continuous Bioprocessing Market Size, by Country, 2017-2027 ($Million)
Table 44 U.S.: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 45 U.S.: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 46 U.S.: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 47 U.S.: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 48 Canada: Key Macro indicators
Table 49 Canada: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 50 Canada: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 51 Canada: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 52 Canada: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 53 Europe: Continuous Bioprocessing Market Size, by Country, 2017-2027 ($Million)
Table 54 Europe: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 55 Europe: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 56 Europe: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 57 Europe: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 58 Germany: Key Macro indicators
Table 59 Germany: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 60 Germany: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 61 Germany: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 62 Germany: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 63 U.K.: Key Macro indicators
Table 64 U.K.: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 65 U.K.: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 66 U.K.: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 67 U.K.: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 68 France: Key Macro indicators
Table 69 France: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 70 France: Continuous Bioprocessing Market Size, By Application, 2017-2027 ($Million)
Table 71 France: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 72 France: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 73 Italy: Key Macro indicators
Table 74 Italy: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 75 Italy: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 76 Italy: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 77 Italy: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 78 Spain: Key Macro indicators
Table 79 Spain: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 80 Spain: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 81 Spain: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 82 Spain: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 83 RoE: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 84 RoE: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 85 RoE: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 86 RoE: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 87 Asia-Pacific: Continuous Bioprocessing Market Size, by Country, 2017-2027 ($Million)
Table 88 Asia-Pacific: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 89 Asia-Pacific: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 90 Asia-Pacific: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 91 Asia-Pacific: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 92 Japan: Key Macro indicators
Table 93 Japan: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 94 Japan: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 95 Japan: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 96 Japan: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 97 China: Key Macro indicators
Table 98 China: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 99 China: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 100 China: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 101 China: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 102 India: Key Macro indicators
Table 103 India: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 104 India: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 105 India: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 106 India: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 107 Cancer Incidence (Number of Cases): 2018-2040
Table 108 RoAPAC: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 109 RoAPAC: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 110 RoAPAC: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 111 RoAPAC: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 112 Latin America: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 113 Latin America: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 114 Latin America: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 115 Latin America: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 116 Middle East & Africa: Continuous Bioprocessing Market Size, by Product, 2017-2027 ($Million)
Table 117 Middle East & Africa: Continuous Bioprocessing Market Size, by Application, 2017-2027 ($Million)
Table 118 Middle East & Africa: Continuous Bioprocessing Market Size for Commercial Applications, by Type, 2017-2027 ($Million)
Table 119 Middle East & Africa: Continuous Bioprocessing Market Size, by End User, 2017-2027 ($Million)
Table 120 Number of Developments by the Major Players During 2016-2019
 
List of Figures 

Figure 1  Research Process
Figure 2  Key Secondary Sources
Figure 3  Primary Research Techniques
Figure 4   Key Executives Interviewed
Figure 5  Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6  Market Sizing and Growth Forecast Approach
Figure 7  Filtration Systems and Consumables Segment Dominated the Global Continuous Bioprocessing Market in 2019
Figure 8  Global Continuous Bioprocessing Market by Application, 2019-2027 ($Million)
Figure 9  Global Continuous Bioprocessing Market by End User, 2019-2027 ($Million)
Figure 10 Continuous Bioprocessing Market, by Region
Figure 11  New Cancer Cases Globally: 2018-2040
Figure 12  Number of Biologics Approved: 2010-2018
Figure 13  New Cancer Cases in Asia And Latin America and Caribbean:2018-2040
Figure 14  Number of Personalized Medicines Approved: 2008-2018
Figure 15  Global Continuous Bioprocessing Market Size, by Product, 2019-2027 ($Million)
Figure 16  Global Continuous Bioprocessing Market Size, by Application, 2019-2027 ($Million)
Figure 17  Total Number of Monoclonal Antibodies Approved by U.S.FDA: 2012-2017
Figure 18  Number of New Molecular Entities (NMEs) and Biologics License Applications (BLAs) Approved by FDA: 2011-2018
Figure 19  Continuous Bioprocessing Market, by End User, 2019-2027 ($Million)
Figure 20 Global Continuous Bioprocessing Market Size, by Region, 2019-2027 ($Million)
Figure 21  North America: Continuous Bioprocessing Market Size, by Country, 2019-2027 ($Million)
Figure 22  Number of Biopharmaceutical Manufacturing Facilities by Country: 2018
Figure 23  New Cancer Cases in Canada: 2017-2040
Figure 24  Total Number of Biosimilars Approved: 2014-2018
Figure 25  Europe: Continuous Bioprocessing Market Size, by Country, 2017-2027 ($Million)
Figure 26  Share of Population Aged 65 And Above (As % Of Total Population), 2011-2018
Figure 27  Number of Biotech Firms in Germany: 2011-2017
Figure 28 Number of New Cancer Cases in U.K.: 2018-2040
Figure 29  Number of Biotech Firms in U.K.: 2016 And 2018
Figure 30  Number of Biotech Firms in Italy: 2009-2018
Figure 31  Population Aged 65 or Over in Spain (As % of Total Population): 2010-2018
Figure 32 Cancer Incidence and Mortality in Spain (Number of Cases): 2018-2040
Figure 33  Cancer Incidence by Country: 2018-2040 (Number of Cases)
Figure 34  Per Capita Health Spending by Country, 2018 (In $)
Figure 35  Asia-Pacific: Continuous Bioprocessing Market Size, by Country, 2019-2027 ($Million)
Figure 36 Cancer Incidence in Japan: 2018-2040
Figure 37  Biosimilars Approved in Japan: 2014-2018
Figure 38  Key Growth Strategies Adopted by Leading Players -2016-2019
Figure 39  Continuous Bioprocessing Market: Competitive Benchmarking
Figure 40  Global Continuous Bioprocessing Market Share, by Key Players, 2018 (%)
Figure 41  GE Healthcare: Financial Overview (2016-2018)
Figure 42  Merck KGaA: Financial Overview (2016-2018)
Figure 43  Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)
Figure 44  Danaher Corporation: Financial Overview (2016-2018)
Figure 45  Sartorius AG: Financial Overview (2016-2018)
Figure 46  Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)
Figure 47  Repligen Corporation: Financial Overview (2016-2018)
Figure 48  Eppendorf AG: Financial Overview (2016-2018)
Figure 49  3M Company: Financial Overview: (2016-2018)


The global continuous bioprocessing market is expected to grow at a CAGR of 8.8% from 2019 to 2027 to reach $7.33 billion by 2027. The continuous bioprocessing is the continuous clinical and commercial production process of biopharmaceutical products using flexible facilities. In continuous manufacturing, the use of single-use products such as flow paths and bioreactor sizes are expected to increase the capital investment of the company with simplified technology transfer activities. The growth in the overall continuous bioprocessing market is majorly driven by growing demand for biopharmaceuticals, development of new technologies and products related to continuous bioprocessing, and rising government support for biopharmaceutical manufacturing. Further, emerging economies such as Asia-Pacific and Latin America and growing approvals for the personalized medicines offer significant growth opportunities for the players operating in the global continuous bioprocessing market.            

Growing demand for biopharmaceuticals is propelling the growth of the continuous bioprocessing market           

With the increasing prevalence of chronic illness across the globe, the biopharmaceuticals have exhibited substantial growth in the overall pharmaceutical market. According to the American Pharmaceutical Review - one of the leading journals in the pharmaceutical industry - the demand for antibody-based products has increased in the recent years; and currently, under the biologic license application (BLA) or equivalent stage of regulatory submission, antibody-based products accounts for ~67% of all the biopharmaceuticals. According to the journal, they contribute ~82% of the products in phase 3 development and ~90% of products in phase 1 and 2 development. In addition, with the increasing demand, the approval for biopharmaceutical products have increased in the recent years. For instance, according to the Creative Biolabs, Inc. (a life science company), the number of antibody approvals has increased in numbers since past 3-4 years. For instance, in 2017, 10 new monoclonal antibodies were approved for commercialization around the world as compared to 3 in 2014.

Therefore, the growing demand for biopharmaceuticals and bioproduction is likely to increase the adoption of continuous bioprocessing, thereby boosting the market growth.

Growing government support for biopharmaceutical industry to drive the market growth

Due to health care concerns, complexities in clinical trials, and higher failure of drugs in early-phase studies, the government funding for healthcare research & development has increased. Some of the notable government initiatives include:

  • In 2018, Indian government launched 'Pharma Vision 2020', which aimed at increasing the production capacities of biopharmaceuticals by reducing the approval time for new facilities. Also, government decided to be in favour of 100% foreign direct investment in the pharmaceutical industry, which is expected to increase the investments in R&D activities by collaboration between biopharmaceutical giants and government.
  • Similarly, in 2017, in the U.S., National Institutes of Health (NIH) collaborated with 11 biopharmaceutical companies to launch the “Partnership for Accelerating Cancer Therapies (PACT)”, five-year public-private research collaboration. The aim of the collaboration is to develop immunotherapy for cancers. The program involves total investment of $215 million.
  • In Japan, in 2015, Ministry of Health, Labour and Welfare (MHLW) introduced the “Sakigake” designation scheme aimed to accelerate the time to market for innovative drugs.
  • Also, in Korea, the government announced the second Basic Development Plan for Bioengineering (2012). According to which, the Korean government increased biotech investments to $8.35 billion (KRW 9.7 trillion) through 2016. In addition, Korean government announced the “Government-wide Mid- to Long-term Action Plans to Promote R&D for National Healthcare” in 2013 to promote the growth of the biotechnology and healthcare industry.

Click here to: Get Free Request Sample Pages of this report

Key findings in the global continuous bioprocessing market study:

Filtration systems and consumables generated large proportion of revenue compared to other product segments

The factors such as growing adoption of single use filters at each step of biopharmaceutical purification and recurrent use of associated consumables are supporting the dominance of filtration systems and consumable segment in the overall continuous bioprocessing market.

Commercial application to register the fastest growth in the continuous bioprocessing market through 2027

The commercial application segment is expected to register the fastest growth in the continuous bioprocessing market during the forecast period of 2019-2027. This growth is mainly due to increase in antibody production, growing approval for biosimilars, and high demand for vaccines due to frequent outbreaks of infectious diseases.

Pharmaceutical & biotechnology companies dominated the global continuous bioprocessing market in 2019

Pharmaceutical and biotechnology companies commanded the largest share of the overall continuous bioprocessing market in 2019. Increasing adoption of continuous bioprocessing related equipment and consumables during biopharmaceutical manufacturing in these companies and relatively greater purchasing power of pharmaceutical and biotechnology companies are the key factors driving the growth of the continuous bioprocessing market for pharmaceutical and biotechnology companies.

Asia-Pacific: The fastest growing regional market

North America commanded the largest share of the overall continuous bioprocessing market in 2019, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific region will be the fastest growing regional market due to accelerated economic growth of many countries in this region; increasing prevalence of chronic illness; and growing government focus towards improvement of biopharmaceutical sector. In addition, facility expansions by the key players and frequent launch of new products are the other key factors propelling the growth of the Asia-Pacific continuous bioprocessing market.

Key Players

The report includes competitive landscape based on the extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 4 years (2016-2020). The key players profiled in the global continuous bioprocessing market report are GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sartorius AG (Germany), Repligen Corporation (U.S.), Eppendorf AG (Germany),3M Company (U.S.), and Applikon Biotechnology B.V. (Netherlands).

Scope of the Report:

Continuous Bioprocessing Market, by Product

  • Filtration Systems and Consumables
  • Chromatography Systems and Consumables
  • Bioreactors
  • Cell Culture Media and Reagents
  • Mixing Systems
  • Incubators & Shakers
  • Centrifuges
  • Sterilizers
  • Other instruments & consumables
  • Services

Note: Other instruments and consumables include bioprocessing container, cartridges, biosafety cabinets, liquid handling systems, membrane adsorber, spare parts, cell disruption reagents, syringes, vials, closures, tubings, connectors, and sensors

Continuous Bioprocessing Market, by Application

  • Commercial Applications
    • Monoclonal Antibody Production
    • Therapeutic Protein Production
    • Vaccine Production
    • Cell and Gene Therapy
  • Research Applications

Continuous Bioprocessing Market, by End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Academic & Research Institutes

 Continuous Bioprocessing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report-

Development of new technologies and products related to continuous bioprocessing will propel the growth of the continuous bioprocessing market

  • How do the advancements in technologies influence the adoption of continuous bioprocessing?
  • How are the leading players incorporating the technological developments in their products?
  • How is the adoption of newly launched products in various regions/countries?

Pharmaceutical & biotechnology companies accounted for the largest share of the overall continuous bioprocessing market

  • What factors are contributing to the adoption of continuous bioprocessing in pharmaceutical & biotechnology companies?
  • Which continuous bioprocessing products are commonly used in pharmaceutical & biotechnology companies?
  • How does the penetration of continuous bioprocessing in pharmaceutical & biotechnology companies differ from other end users?

The North American continuous bioprocessing market favors both larger and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter this market use to compete effectively?
  • What are the major drivers, restraints, opportunities, challenges, and trends in the global continuous bioprocessing market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent new product launches and approvals; product enhancements; agreements, partnerships, and collaborations; acquisitions; and expansions have taken place in the continuous bioprocessing market space

  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the continuous bioprocessing market?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global continuous bioprocessing market and what share of the market do they hold?
  • What are the local emerging players in the global continuous bioprocessing market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare biopharmaceuticals Medical Technologies
Download Free Sample